Loading…
Myotonic disorders
Myotonia reflects a state of muscle fiber hyperexcitability. Impaired transmembrane conductance of either chloride or sodium ions results in myotonia. Myotonic disorders include the myotonic dystrophies and nondystrophic myotonias. Mutations in the genes encoding chloride (ClC-1) or sodium (SCN4A) c...
Saved in:
Published in: | Neurology India 2008-07, Vol.56 (3), p.298-304 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Myotonia reflects a state of muscle fiber hyperexcitability. Impaired
transmembrane conductance of either chloride or sodium ions results in
myotonia. Myotonic disorders include the myotonic dystrophies and
nondystrophic myotonias. Mutations in the genes encoding chloride
(ClC-1) or sodium (SCN4A) channels expressed exclusively in skeletal
muscle cause nondystrophic myotonias. Genetic defects in the myotonic
dystrophies do not involve ion channel or its regulator proteins.
Recent research supports a novel RNA-mediated disease mechanism of
myotonia in the myotonic dystrophies. Myotonic dystrophy Type 1 is
caused by CTG repeat expansion in the 3′ untranslated region in
the Dystrophia Myotonica Protein Kinase (DMPK) gene. Myotonic dystrophy
Type 2 is caused by CCTG repeat expansion in the first intron in Zinc
Finger Protein 9 (ZNF9) gene. The expanded repeat is transcribed in RNA
and forms discrete inclusions in nucleus in both types of myotonic
dystrophies. Mutant RNA sequesters MBNL1, a splice regulator protein
and depletes MBNL1 from the nucleoplasm. Loss of MBNL1 results in
altered splicing of ClC-1 mRNA. Altered splice products do not encode
functional ClC-1 protein. Subsequent loss of chloride conductance in
muscle membrane causes myotonia in the myotonic dystrophies. The
purpose of this review is to discuss the clinical presentation, recent
advances in understanding the disease mechanism with particular
emphasis on myotonic dystrophies and potential therapy options in
myotonic disorders. |
---|---|
ISSN: | 0028-3886 1998-4022 |
DOI: | 10.4103/0028-3886.43448 |